Non-Coding RNAs therapeutic potential and NextRNA innovative solutions

A complete (from idea to screen) 3D visualization solution that grasps the attention and brings closer the Non-Coding RNAs’ therapeutic potential and NextRNA’s innovative solutions to potential investors, field experts and the broader scientific public.
 

 

Helix’s team is especially keen to work with innovative companies and start-ups from the biotechnology sector, as we get to meet and team up with exceptional people and pioneers of science, who are working on incredible projects that push the edge in healthcare innovations.

 

NextRNA Therapeutics is one of those companies, with whom we partnered to develop vivid 3D visualization solutions. It is a Boston based biotechnology company that launched in March 2022 with $56 Million in Series A funding, and aims to revolutionize RNA-directed therapeutics, by unlocking the therapeutic potential of non-coding RNAs.

 

The objective was to grasp the attention and bring closer to potential investors, field experts and the broader scientific public the Non-Coding RNAs’ therapeutic potential and NextRNA Tx innovative solutions, through a complete (from idea to screen) 3D visualization solution. We were thrilled to work closely with NextRNA's team to transform the provided scientific inputs and vision, into a top-notch scientific 3D animation and additional visual assets for web and other purposes, that convey to both experts and well-informed broader audience their innovative science in a scientifically accurate, eye catching and easy to understand way.
 

 

 

Interestingly, non-coding RNAs were firstly considered to be non-functional, while today it has been shown that they have an important role in the cells and drive cell disease processes. Therefore, they have gained increased research interest in various areas such as oncology, immunology, and neurology among others.

 

“By understanding the interactions between long non-coding RNAs and specific proteins, we can decode the function of long non-coding RNAs and apply it to create medicines,” said Dr. Novina, co-founder of NextRNA in their website post.
 

 

 

This kind of visuals enable Pharma, Biotech, and Medical Device companies to successfully convey complex messages to their target audience. Whether they are meant for investors, end customers, or governmental agencies, once a 3D medical visualization is created, it can have versatile usage and can be easily customized depending on the needs and informational purposes.



If you'd like to learn more on how we can help you bring your healthcare solutions to screen in a clear and compelling way, the typical process and related costs, you can schedule a free consultation at any time via our Contact Form available below.